← FDA DRUG APPROVALS

FDA NDA · NDA021247

AEROSPAN HFA

Sponsor: PHARMOBEDIENT

APPLICATION
NDA021247
TYPE
NDA
ORIGINAL APPROVAL
2006-01-27
LATEST ACTION
2018-04-25
ROUTE
INHALATION
DOSAGE FORM
AEROSOL, METERED
MARKETING STATUS
Discontinued

Products

AEROSPAN HFA · ReferenceDiscontinued
FLUNISOLIDE 0.078MG/INH · AEROSOL, METERED · INHALATION

Approval history

2018-04-25Labeling · Supplement 17 · standardLabelAP
2017-11-17Labeling · Supplement 16 · standardLabelAP
2017-06-23Labeling · Supplement 15 · standardLabelAP
2016-04-22Manufacturing (CMC) · Supplement 14 · standardAP
2016-03-09Manufacturing (CMC) · Supplement 13 · standardAP
2015-02-09Manufacturing (CMC) · Supplement 12 · standardAP
2014-02-14Manufacturing (CMC) · Supplement 11 · standardAP
2013-12-09Manufacturing (CMC) · Supplement 10 · standardAP
2013-09-30Manufacturing (CMC) · Supplement 9 · standardAP
2013-08-28Efficacy · Supplement 8 · standardLetterAP
2012-11-16Labeling · Supplement 7 · standardLabelAP
2006-01-27Type 3 - New Dosage Form · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →